INFLIXIMAB TREATMENT IN IBD: FROM THEORY TO CLINICAL PRACTICE
sabato 19 settembre 2020
Biosimilars are increasingly used to treat ibd patients. Subcutaneous infliximab is now available in IBD.
As intra venous infliximab can be used for every ibd patient refractory to standard treatment its sub cut formulation could be a game changer in routine practice.